TrialAssure Gets New Patent for Date Offset Anonymization Technology in U.S.

Canton Township-based technology company TrialAssure has been granted a utility patent from the U.S. Patent and Trademark Office for its data offset anonymization method called ANONYMIZE.
158
Computer
TrialAssure’s ANONYMIZE software allows the user to more easily anonymize data. It received a utility patent for the technology. // Stock photo

Canton Township-based technology company TrialAssure has been granted a utility patent from the U.S. Patent and Trademark Office for its data offset anonymization method called ANONYMIZE.

The technology allows the user to improve the protection of data by making the anonymization in clinical trial documents. It applies a user-defined ruleset tied to a specific date, then modifies all subject-related dates using calculated offset values.

“This patent award is further proof of the strength of our technology team and our long-term investment in developing smart, auditable anonymization processes that align with global data sharing requirements,” says Prasad M. Koppolu, COO of TrialAssure.

“We are proud to blend AI advancement with the right level of human knowledge to push boundaries globally and provide our customers with innovative tools that protect privacy and maintain utility.”

In addition to replacing subject-specific dates, the patented system provides a summary display of anchor dates, offsets, original dates, and their anonymized counterparts. This transparency enables better reviewer understanding, reproducibility, and regulatory confidence.

As the importance of data protection rises in importance and difficulty, TrialAssure’s ANONYMIZE should help companies in a variety of industries, including pharmaceutical, biotechnology, and medical device.

The platform’s strengths come from AI-guided automation supported by expert oversight. It also supports global data sharing standards, features a centralized and real-time workbench that improves review collaboration, decision tracking, and audit readiness. While the catalyst for development was the pharmaceutical industry, TrialAssure officials say it can be used for legal, finance, and transportation applications.